4//SEC Filing
Alpine ImmunoSciences, L.P. 4
Accession 0000899243-20-034853
CIK 0001626199other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 5:30 PM ET
Size
7.7 KB
Accession
0000899243-20-034853
Insider Transaction Report
Form 4
Alpine Bioventures GP, LLC
10% Owner
Transactions
- Other
Common Stock
2020-12-22−993,801→ 3,000,980 total
Alpine ImmunoSciences, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-12-22−993,801→ 3,000,980 total
Footnotes (2)
- [F1]Alpine ImmunoSciences, L.P. distributed these shares to its limited partners on a pro rata basis for no consideration.
- [F2]Alpine BioVentures GP, LLC ("ABV LLC") is the general partner of the Reporting Person. Dr. Mitchell Gold and Dr. Jay Venkatesan are the Managing Partners of ABV LLC. Dr. Gold and Dr. Venkatesan are also limited partners of the Reporting Person. By virtue of their positions as Managing Partners of ABV LLC, Dr. Gold and Dr. Venkatesan may be deemed to have voting and investment power with respect to the shares held by the Reporting Person and as a result may be deemed to have beneficial ownership of such shares. Each of Dr. Gold and Dr. Venkatesan disclaims beneficial ownership of the shares held by the Reporting Person, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person, Dr. Gold or Dr. Venkatesan is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Documents
Issuer
ALPINE IMMUNE SCIENCES, INC.
CIK 0001626199
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001628571
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 5:30 PM ET
- Size
- 7.7 KB